Menu
Back to User profile » Dr Christopher B Cooper
Papers published by Dr Christopher B Cooper:
Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD
Park SC, Saiphoklang N, Phillips J, Wilgus ML, Buhr RG, Tashkin DP, Cooper CB, Barjaktarevic I
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1475-1486
Published Date: 18 July 2023
Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
Zou C, Li F, Choi J, Haghighi B, Choi S, Rajaraman PK, Comellas AP, Newell Jnr JD, Lee CH, Barr RG, Bleecker E, Cooper CB, Couper D, Han M, Hansel NN, Kanner RE, Kazerooni EA, Kleerup EC, Martinez FJ, O'Neal W, Paine III R, Rennard SI, Smith BM, Woodruff PG, Hoffman EA, Lin CL
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1477-1496
Published Date: 31 May 2021
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
Stott-Miller M, Müllerová H, Miller B, Tabberer M, El Baou C, Keeley T, Martinez FJ, Han M, Dransfield M, Hansel NN, Cooper CB, Woodruff P, Ortega VE, Comellas AP, Paine R III, Kanner RE, Anderson W, Drummond MB, Kim V, Tal-Singer R, Lazaar AL
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2467-2476
Published Date: 13 October 2020
Remote Patient Monitoring for the Detection of COPD Exacerbations
Cooper CB, Sirichana W, Arnold MT, Neufeld EV, Taylor M, Wang X, Dolezal BA
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2005-2013
Published Date: 24 August 2020
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the Spiromics Cohort
Cooper CB, Paine R, Curtis JL, Kanner RE, Martinez CH, Meldrum CA, Bowler R, O'Neal W, Hoffman EA, Couper D, Quibrera M, Criner G, Dransfield MT, Han MK, Hansel NN, Krishnan JA, Lazarus SC, Peters SP, Barr RG, Martinez FJ, Woodruff PG
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1887-1898
Published Date: 4 August 2020
Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis
Allwood BW, Maasdorp E, Kim GJ, Cooper CB, Goldin J, van Zyl-Smit RN, Bateman ED, Dawson R
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1039-1047
Published Date: 11 May 2020
The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease
Galiatsatos P, Woo H, Paulin LM, Kind A, Putcha N, Gassett AJ, Cooper CB, Dransfield MT, Parekh TM, Oates GR, Barr RG, Comellas AP, Han MK, Peters SP, Krishnan JA, Labaki WW, McCormack MC, Kaufman JD, Hansel NN
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:981-993
Published Date: 5 May 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine III R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:901-902
Published Date: 23 April 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine III R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2927-2938
Published Date: 20 December 2019
Statistical Process Control Improves The Feasibility Of Remote Physiological Monitoring In Patients With Chronic Obstructive Pulmonary Disease
Cooper CB, Sirichana W, Neufeld EV, Taylor M, Wang X, Dolezal BA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2485-2496
Published Date: 13 November 2019
Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
Barjaktarevic I, Kaner R, Buhr RG, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3511-3513
Published Date: 23 October 2018
Positioning new pharmacotherapies for COPD
Barjaktarevic IZ, Arredondo AF, Cooper CB
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1427-1442
Published Date: 24 July 2015
Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S
International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:269-275
Published Date: 9 May 2011
Development and implementation of treadmill exercise testing protocols in COPD
Christopher B Cooper, Marlon Abrazado, Daniel Legg, et al
International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:375-385
Published Date: 12 October 2010
Desensitization to dyspnea in COPD with specificity for exercise training mode
Christopher B Cooper
International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:33-43
Published Date: 28 September 2008